Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Scientific knowledge and evidence-based findings inform researchers to plan additional research and in-vitro procedures, but do not imply therapeutic or clinical results
Hematocrit and reticulocyte counts should be repeated daily from the fifth to seventh days of therapy and then frequently until the hematocrit is normal
Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) As Induction Therapy in Patients with Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Zhang, W
Great Great product
US$ 26.12
US$ 26.16
US$ 24.47
